Current Treatment Options in Oncology
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 5.8 | Q1 | 80.2% | 1.626 | Q1 | 93.1% |
| 2024 | 4.7 | Q1 | 76.7% | 1.335 | Q1 | 90.4% |
| 2023 | 3.8 | Q2 | 64.7% | 1.326 | Q1 | 91.0% |
| 2022 | 4.3 | Q2 | 64.8% | 1.118 | Q1 | 88.6% |
| 2021 | 5.1 | Q2 | 68.1% | 1.347 | Q1 | 91.7% |
| 2020 | — | — | 1.457 | Q1 | 92.0% | |
| 2019 | — | — | 1.310 | Q1 | 90.6% | |
| 2018 | — | — | 1.570 | Q1 | 92.5% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1527-2729
ISSN
1534-6277
country
UScoverage
2000-2026